-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_consumer.pdf
May 01, 2011 - Some common names for these drugs are
morphine, codeine, and oxycodone. … Nonsteroidal anti-inflammatory drugs or NSAIDs. … Some common
names for these drugs are ibuprofen and naproxen.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
November 01, 2017 - characteristics
(e.g., age, type and dose of opioid involved in overdose,
or involvement of other drugs … in overdose, response
to naloxone (e.g., based on Glasgow Coma Scale score),
other substances and drugs … Amphastar Pharmaceuticals. FDA Advisory Committee Briefing
Materials. … Amphastar Pharmaceuticals. … opioide overdose 2016. http://www.fda.gov/downloads/
AdvisoryCommittees/CommitteesMeetingMaterials/Drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
December 22, 2014 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Telaprevir’s manufacturer, Vertex Pharmaceuticals, withdrew the
drug from the market in September 2014 … Viekira Pak: The Viekira Pak (AbbVie, North Chicago, IL, and Enanta Pharmaceuticals,
Inc., Watertown … In 2013, the plan spent $377 million for pharmaceuticals for all of its 600,000 members.
7
Oregon … Cambridge (MA):
Vertex Pharmaceuticals; 2011 May. 23 p.
3. Ferenci P.
-
effectivehealthcare.ahrq.gov/health-topics/diabetes-0
August 04, 2010 - Series Overview
February 15, 2011
Data Points #9: Utilization of antidiabetic drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
February 01, 2015 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Results
The table below lists the two topics for which (1) preliminary phase III data for drugs were … Repurposing diabetes
drugs for brain insulin resistance in Alzheimer
disease. … CNS Drugs. 2014
Dec;28(12):1185-9. … CNS Drugs. 2013 Jul;27(7):505-14.
Also available: http://dx.doi.org/10.1007/s40263-
013-0076-8.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-evidence-exists-for-programs-to-increase-patient-adherence-to-prescription-medications-which-programsapproaches-are-most-effective-at-increasing-adherence-for-which-populations-and-conditions-if-little-or-no-evidence-exi
August 12, 2009 - no
If yes, explain the specific technologies, devices, drugs, or interventions you would like to … “Drugs don’t work in patients who don’t take them.” C. Everett Koop, M.D.
-
effectivehealthcare.ahrq.gov/products/bipolar-disorder-treatment/final-report-2018
August 07, 2018 - We synthesized evidence from 157 unique studies, 108 studies for 28 drugs, 49 studies for nondrug interventions … For drugs not approved for BD, paliperidone improved acute mania compared to placebo (low-strength evidence
-
effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
October 01, 2007 - Patients With the Same Treatment Indication:
“Alternative Drug Users”
Selecting comparison drugs that … have the same per-
ceived medical indication for head-to-head comparisons of
active drugs will reduce … In studies of the effectiveness of drugs, it is question-
able whether to include patients who have a … In routine care, adherence to drugs is unfortunately
substantially lower than in RCTs. … Selective prescribing can lead
to over-estimation of the benefits of lipid-lowering drugs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - Oral DMARDs
Anti-‐tumor
necrosis
factor
drugs
vs.
… Oral DMARDs
Anti-tumor necrosis factor drugs vs. … Oral DMARDs
Anti-tumor necrosis factor drugs vs. … Oral DMARDs
Anti-tumor necrosis factor drugs vs. … Oral DMARDs
Anti-tumor necrosis factor drugs vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - Oral DMARDs
Anti-‐tumor
necrosis
factor
drugs
vs.
… Oral DMARDs
Anti-tumor necrosis factor drugs vs. … Oral DMARDs
Anti-tumor necrosis factor drugs vs. … Oral DMARDs
Anti-tumor necrosis factor drugs vs. … Oral DMARDs
Anti-tumor necrosis factor drugs vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
March 01, 2013 - Study
did not compare specific drugs. … Association between disease-modifying
antirheumatic drugs and diabetes risk in
patients with rheumatoid … Association between systemic antipsoriatic
drugs and cardiovascular risk in patients
with psoriasis … Evidence Table
Author, Year Study Design Study name Drugs Year
conducted
N,
Population
F/U … Author, Year Study Design Study name Drugs Year
conducted
N,
Population
F/U
Length
Efficacy
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
November 01, 2023 - update for baclofen and 7 new trials for topiramate, and a small
number of studies reported on some drugs … With the help of our technical expert panel, we
limited drugs with off-label uses to those that are … Therefore,
some drugs reviewed as emerging therapies and some only available outside the United
States … In terms of results, our assessment of the effects of those drugs with
Food and Drug Administration
-
effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-update/final-report-update-2018
July 16, 2018 - discontinuations because of adverse events may not differ between any disease-modifying antirheumatic drugs … and summary tables within and between corticosteroids and classes of disease-modifying antirheumatic drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
June 01, 2015 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Results
The table below lists the three topics for which (1) preliminary phase III data for drugs or … Safety of antiobesity drugs. Ther Adv Drug Saf.
2013;4(4):171-81. … Anti-
obesity drugs: Past, present and future. Dis Model
Mech. 2012 Sep;5(5):621-6.
-
effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
October 01, 2007 - Nurses coded causative drugs
into major classes. … Fewer
classes of drugs commonly cause bleeding. … to these mechanisms are warfa-
rins, heparins, antiplatelet agents, nonsteroidal anti-inflam-
matory drugs … We derived a list of codes reflecting indications where
guidelines17,18 dictate the use of drugs that … Development of models was greatly facilitated by focusing
on the group estimated to be exposed to drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
August 01, 2018 - Some drugs aim to reduce symptoms associated with acute
manic or mixed mania/depression episodes, some … For drugs not approved for BD,
paliperidone also improved acute mania compared to
placebo (low-strength … a number of
observational studies being excluded, including those
that looked at broad classes of drugs … , or individual drugs
across broad populations. … However,
none of the drugs reached MID.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/the-american-college-of-chest-physicians-accp-proposes-to-update-the-following-4-guideline-topics-from-the-2006-publication-on-the-diagnosis-and-management-of-cough-accp-evidence-based-clinical-practice-guidelines1-1-assessin
January 01, 2006 - yes
If yes, explain the specific technologies, devices, drugs, or interventions you would like to … Complications caused by coughing as well as adverse drugs reactions due to cough suppressants or protussive … manage the unexplained, refractory chronic cough in adults, and 4) to know which cough antisuppressant drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
April 01, 2012 - Coordinating Council for Comparative Effectiveness Research,
AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar
drugs in the … The table below lists the three topics for which (1) preliminary phase III were
available for drugs … Impact
Interventions Report, we aggregated related topics for summary and discussion (e.g., individual drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
January 01, 2023 - Some opioids may be less
effective than other drugs. … Key Messages
• Opioids are probably less effective than
nonsteroidal anti-inflammatory drugs (NSAIDs … by the Centers for Disease
Control and Prevention, evaluates the benefits and
harms of nonopioid drugs … Key Messages
As initial therapy in the prehospital setting:
• Nonsteroidal anti-inflammatory drugs … Key Messages
As initial therapy in the prehospital setting:
Nonsteroidal anti-inflammatory drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioids-oa-protocol.pdf
June 29, 2019 - many older adults are
unable to tolerate non-opioid analgesics (e.g., non-steroidal anti-inflammatory drugs … Cyclooxygenase-2
selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction … Do selective cyclo-oxygenase-2
inhibitors and traditional non-steroidal anti-inflammatory drugs increase … A metaanalysis of severe upper
gastrointestinal complications of nonsteroidal antiinflammatory drugs … Meta-analysis of dyspepsia and
nonsteroidal antiinflammatory drugs.